NVO cup and handle cheat entryCheat entry at $137.8. Stop-loss at $133.30 and take-profit at $146.9. Enter only after the breakout.
Key facts today
Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
2.92USD
12.14 BUSD
33.70 BUSD
3.34 B
About NOVO NORDISK B A/S
Sector
CEO
Lars Fruergaard Jørgensen
Headquarters
Bagsværd
Website
Employees (FY)
63.37 K
Founded
1931
FIGI
BBG000BQBKR3
Novo Nordisk A/S is a global healthcare company, which engages in the discovery, development, manufacturing and marketing of pharmaceutical products. It operates through the Diabetes and Obesity Care, and Rare Disease segments. The Diabetes and Obesity Care segment includes diabetes, obesity, cardiovascular, and emerging therapy areas. The Rare Disease segment refers to rare blood disorders, rare endocrine disorders, and hormone replacement therapy. The company was founded by Harald Pedersen and Thorvald Pedersen in 1923 is headquartered in Bagsværd, Denmark.
How To Pick Top Pharma Stocks like a ProAnalyzing the pharmaceutical industry, whose products play a key role in improving the quality of life of people around the world, is quite challenging sometimes also it requires deep knowledge and a careful approach, as I believe that investors should consider many factors, starting with evaluating
Novo Nordisk: Analyzing a Potential Pullback and Key levelsLong-Term Overview (3M Timeframe)
Looking at the 3-month timeframe, we can observe that OMXCOP:NOVO_B
has maintained a consistent bullish trend channel since 1990, characterized by higher highs and higher lows.
Medium-Term Analysis (1M Timeframe)
On the one-month timeframe, since the last
NVO hit downside price targetNVO just hit the downside price target with this recent market pullback, this momentum trend has been in effect since Nov 2022. I expect this to pick back up with a possible wick slightly lower than here. I think we see a retest to 142$ in the coming weeks. I am debating adding LEAPs on this bad boy
I see an H&S formationLooking at the chart and volumes of NYSE:NVO , I guess that we have a high probability of an H&S pattern formation. Waiting for a confirmation or an invalidation
Novo Showing Bullish SignsHello everyone, happy Sunday. Today I am presenting my "cup and handle" bullish pattern on $NYSE:NVO. From a technical perspective, the stock has shown a typical cup pattern with resistance, and I expect a handle to soon form before a bullish continuation upwards. Currently in with 75 shares around
$NVO Become a New Watch List?!NYSE:NVO is a new watchlist since it keeps forming a very good bullish structure.
Let's see where it goes.
Novo Nordisk's Wegovy Secures China Approval, Poised for Major MDanish pharmaceutical giant Novo Nordisk gains significant access with the approval of its weight-loss drug Wegovy in China. This move grants Novo Nordisk entry into the world's second-largest economy, targeting a growing population facing obesity challenges.
Key Considerations:
Wegovy target
Update on NVO swingI charted my entry on the dotted green, I did go with calls for June 21st, I am debating closing them now before theta decay starts to really ramp up, but I still think we might hit 144-145$ in a few days the way this is going. The stochastic RSI still has room to run a few more days and the stock l
NVO: Super-Duper-To-GoFundamentals:
An insulin and diabetes drug care company based in Denmark. Booming fundamentals, booming funds, great cashflow, stable earnings and accelerating sales. Pays a little dividend.
Technicals:
Shallow pb
uHd
extreme indicator
34%-50% pb
a-b-c pb completion
horizonal support
kijun bounc
See all ideas
An aggregate view of professional's ratings.
Curated watchlists where NVO is featured.
